ARF6 and pancreatic ductal adenocarcinoma: For example, KRAS and TP53 oncogenes could promote PD-L1 recycling and cell surface expression through ARF6-AMAP1 pathway, which is significantly involved in the immune evasion of pancreatic ductal adenocarcinoma cells [72].